Controlled-Release Drug Delivery Systems for Anti-inflammatory and Wound Healing Action

Dear Colleagues,

We are pleased to invite you to contribute to this new Special Issue, entitled “Controlled-Release Drug Delivery Systems for Anti-inflammatory and Wound Healing Action”.

Wound healing represents a natural bodily reaction that is formed as a tissue response to injury. The restoration of the structural and functional integrity of injured tissues is a highly coordinated process involving various overlapping phases such as hemostasis, inflammation, proliferation, and maturation. In recent years, drug delivery systems (DDSs) with controlled release have attracted considerable attention in wound healing and inflammation management due to their significant benefits compared to conventional drugs. The advantages of controlled DDSs for oral administration include enhanced bioavailability, the protection of the drug from metabolic deactivation and the maintenance of the drug concentration over a prolonged period. On the other hand, DDSs with controlled release intended for cutaneous application have led to improvements in drug permeation and modified release at a physiologically relevant rate.

The scope of this Special Issue includes the design and assessment of DDSs for the delivery of active compounds in pharmaceutical formulations with the potential to accelerate wound repair and reduce inflammation in various acute and chronic conditions.

This Special Issue welcomes the submission of articles that address the following topics: the development of DDSs; physicochemical characterization; the evaluation of rheological properties; stability tests; and in silico, in vitro and in vivo assessments of their anti-inflammatory and wound-healing effects. Moreover, formulations based on medicinal plants and natural products that act as major sources of wound healing and anti-inflammatory compounds are of particular interest.

Dr. Vladimir Zivkovic
Dr. Jovana Bradic
Dr. Anica M. Petrović
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• controlled drug delivery systems
• systems for topical delivery
• physicochemical characterization
• stability studies
• rheological properties
• release and permeation testing
• anti-inflammatory properties
• wound-healing properties
• natural products